GRID1
Basic information
Region (hg38): 10:85599552-86366795
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- GRID1-associated neurodevelopmental disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GRID1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 79 | 82 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 1 | 0 | 80 | 0 | 2 |
Variants in GRID1
This is a list of pathogenic ClinVar variants found in the GRID1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-85602319-C-T | not specified | Uncertain significance (Mar 29, 2022) | ||
10-85602353-G-A | GRID1-associated neurodevelopmental disorder | Uncertain significance (May 08, 2023) | ||
10-85602364-G-A | not specified | Uncertain significance (Jul 25, 2023) | ||
10-85602448-G-A | GRID1-associated neurodevelopmental disorder | Uncertain significance (May 08, 2023) | ||
10-85602550-C-T | not specified | Uncertain significance (Mar 22, 2023) | ||
10-85602613-G-A | GRID1-associated neurodevelopmental disorder | Uncertain significance (May 08, 2023) | ||
10-85602637-G-A | not specified | Uncertain significance (Apr 15, 2024) | ||
10-85602667-C-T | Uncertain significance (Jan 13, 2022) | |||
10-85613411-T-C | not specified | Uncertain significance (Aug 26, 2022) | ||
10-85613417-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
10-85613433-G-A | not specified | Uncertain significance (Oct 06, 2022) | ||
10-85613478-G-C | not specified | Uncertain significance (Nov 14, 2023) | ||
10-85613559-C-T | GRID1-associated neurodevelopmental disorder | Uncertain significance (May 08, 2023) | ||
10-85619901-G-A | not specified | Uncertain significance (Dec 28, 2022) | ||
10-85619957-G-A | not specified | Uncertain significance (Jan 30, 2024) | ||
10-85619972-G-A | GRID1-associated neurodevelopmental disorder | Uncertain significance (May 08, 2023) | ||
10-85647243-C-A | not specified | Uncertain significance (Feb 05, 2024) | ||
10-85647249-C-T | GRID1-associated neurodevelopmental disorder • not specified | Uncertain significance (May 08, 2023) | ||
10-85647275-T-C | GRID1-associated neurodevelopmental disorder | Uncertain significance (May 08, 2023) | ||
10-85647320-C-T | not specified | Uncertain significance (Jun 18, 2024) | ||
10-85647339-C-T | not specified | Uncertain significance (Aug 28, 2023) | ||
10-85647345-C-G | GRID1-associated neurodevelopmental disorder | Uncertain significance (May 08, 2023) | ||
10-85723052-C-T | GRID1-associated neurodevelopmental disorder | Pathogenic (May 08, 2023) | ||
10-85723089-C-A | not specified | Uncertain significance (Sep 29, 2022) | ||
10-85723106-T-G | not specified | Uncertain significance (Aug 15, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GRID1 | protein_coding | protein_coding | ENST00000327946 | 16 | 766939 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.000691 | 125738 | 0 | 10 | 125748 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.62 | 509 | 622 | 0.818 | 0.0000385 | 6642 |
Missense in Polyphen | 204 | 287.61 | 0.7093 | 3044 | ||
Synonymous | -0.369 | 272 | 264 | 1.03 | 0.0000180 | 2000 |
Loss of Function | 5.37 | 5 | 43.1 | 0.116 | 0.00000193 | 477 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000578 | 0.0000578 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000708 | 0.0000703 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for glutamate. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. The postsynaptic actions of Glu are mediated by a variety of receptors that are named according to their selective agonists.;
- Pathway
- Neuroactive ligand-receptor interaction - Homo sapiens (human);MECP2 and Associated Rett Syndrome
(Consensus)
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- loftool
- 0.108
- rvis_EVS
- -2.1
- rvis_percentile_EVS
- 1.55
Haploinsufficiency Scores
- pHI
- 0.403
- hipred
- Y
- hipred_score
- 0.685
- ghis
- 0.626
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.351
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Grid1
- Phenotype
- growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; skeleton phenotype;
Gene ontology
- Biological process
- ion transmembrane transport;social behavior;ionotropic glutamate receptor signaling pathway;synaptic transmission, glutamatergic;modulation of chemical synaptic transmission
- Cellular component
- plasma membrane;cell junction;postsynaptic membrane;extracellular exosome;glutamatergic synapse;integral component of postsynaptic density membrane
- Molecular function
- ionotropic glutamate receptor activity;glutamate receptor activity;transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential